DF
ABMD

Donoghue Forlines’s Abiomed Inc ABMD Stock Holding History

Donoghue Forlines’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-959
Closed -$236K – 278
2022
Q3 		$236K Sell
959
-1,556
-62% -$420K 0.09% 202
2022
Q2 		$622K Sell
2,515
-288
-10% -$77.7K 0.16% 170
2022
Q1 		$928K Buy
2,803
+816
+41% +$251K 0.2% 149
2021
Q4 		$714K Buy
1,987
+444
+29% +$150K 0.12% 188
2021
Q3 		$502K Buy
+1,543
New +$523K 0.1% 186
2021
Q1 		– Sell
-2,466
Closed -$799K – 318
2020
Q4 		$799K Sell
2,466
-2,557
-51% -$707K 0.15% 169
2020
Q3 		$1.39M Buy
+5,023
New +$1.45M 0.38% 46
2018
Q3 		– Sell
-5,388
Closed -$2.2M – 200
2018
Q2 		$2.2M Buy
+5,388
New +$1.95M 0.18% 92

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Donoghue Forlines's ABMD Position: Q4 2022 in Review

Donoghue Forlines sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 959 shares — an estimated $236K sold.

Donoghue Forlines first reported a position in ABMD in Q2 2018 and held it in 8 quarters. The position peaked at $2.2M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Donoghue Forlines reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Donoghue Forlines sold 959 Abiomed Inc shares in Q4 2022, an estimated $236K.
  • Donoghue Forlines first reported a position in Abiomed Inc in Q2 2018 and held it in 8 quarters.
  • Donoghue Forlines's Abiomed Inc position peaked at $2.2M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Donoghue Forlines's 13F filing for Q4 2022, filed 8 Feb 2023.